Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years
- 1 March 1998
- Vol. 51 (3) , 389-396
- https://doi.org/10.1016/s0090-4295(98)00004-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Randomised Study of Casodex 50 Mg Monotherapy vs Orchidectomy in the Treatment of Metastatic Prostate CancerScandinavian Journal of Urology and Nephrology, 1996
- A controlled trial of bicalutamide versus castration in patients with advanced prostate cancerUrology, 1996
- Worldwide activity and safety of bicalutamide: a summary reviewUrology, 1996
- Flutamide HepatotoxicityJournal of Urology, 1996
- Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinomaUrology, 1995
- Health-related quality of life in patients with advanced prostate cancer: A multinational perspectiveQuality of Life Research, 1995
- Current clinical studies with a new nonsteroidal antiandrogen, casodexThe Prostate, 1994
- Patient preferencesJournal of General Internal Medicine, 1993
- NilutamideDrugs & Aging, 1993
- Flutamide versus Stilboestrol in the Management of Advanced Prostatic Cancer: A Controlled Prospective StudyBritish Journal of Urology, 1988